Revolutionizing Healthcare Through Genetic Transparency and Choice|Anne Wojcicki, CEO, 23andme holding co. 00:10:00

Share On Facebook Share On Twitter

Anne Wojcicki, Co-founder and CEO of 23andMe, discusses the transformative potential of genetic transparency and choice in revolutionizing healthcare, emphasizing the importance of trust, statistical power, and equity in genomics.

Recent Videos